Please login to the form below

Not currently logged in
Email:
Password:

Lilly honours mental health charity workers

Eli Lilly & Co has honoured six people working to improve the quality of life for people suffering from depression at the 10th Annual Welcome Back Awards
Eli Lilly & Co has honoured six people working to improve the quality of life for people suffering from depression at the 10th Annual Welcome Back Awards.

During a ceremony which took place in Washington DC, Lilly presented a new award to mark a decade of promoting and supporting activists working with mental health patients. Rory White, founding manager of the Skid Row Lamp Art Project in Los Angeles, was named Person of the Decade.

White said: "Bringing validation to programmes like mine, the Welcome Back Awards has helped create a legacy that will work to banish the stigma of mental illness for years to come."

The Welcome Back Awards were created by Lilly in 1998. Honourees working within fields such as psychiatry, primary care and community service are selected by an independent panel of US mental health experts.

"Each of the winners is a pioneer, bringing depression awareness to their individual communities and the country at large," said Dr Rakesh Jain, Welcome Back Awards committee member and director of psychiatric drug research at R/D Clinical Research Centre in Lake Jackson, Texas.

The company donates between $10,000 and $15,000 to a not-for-profit organisation of each winnerís choice. In the decade it has been in operation, Lilly has used the Awards to give away almost $500,000.

Dr John Hayes, vice-president of Lilly Research Laboratories and global brand development team leader of neuroscience for Lilly, said: "It is important for Lilly to recognise these unique voices in the depression community as a way to inspire them to continue their good work and promote recovery."

2nd May 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics